21. Development of monoclonal antibody products targeting SARS-CoV-2 for emergency use authorization: guidance for industry Publication: Silver Spring, MD : Center for Drug Evaluation and Research, December 2023 Subject(s): Antibodies, MonoclonalCOVID-19 Drug TreatmentDrug ApprovalDrug IndustryGovernment RegulationLegislation, DrugSARS-CoV-2United States
22. Registration and listing of cosmetic product facilities and products: guidance for industry Publication: Silver Spring, MD : Office of the Chief Scientist, December 2023 Subject(s): Cosmetics -- legislation & jurisprudenceDrug IndustryGovernment RegulationLegislation, DrugManufacturing and Industrial Facilities -- legislation & jurisprudenceUnited States